During the past decade, Gansu Cancer Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gansu Cancer Hospital" #1 sponsor was "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials, followed by "BeiGene" with 1 trials sponsored, "China Breast Cancer Clinical Study Group" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Qilu Pharmaceutical Co., Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Gansu Cancer Hospital" are "Abiraterone Acetate" (1 trials), "Androgens" (1 trials), "Antineoplastic Agents" (1 trials), "Antineoplastic Agents, Hormonal" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Gansu Cancer Hospital" in a lesser frequency.

Most popular intervention types in "Gansu Cancer Hospital" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "5-Fu/epirubicin/CTX following Docetaxel" (1 trials), "Abemaciclib" (1 trials), "Abiraterone" (1 trials), "Anlotinib" (1 trials) and "Concurrent Chemoradiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gansu Cancer Hospital" are 4 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gansu Cancer Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Gansu Cancer Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gansu Cancer Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Gansu Cancer Hospital has several departments that took part in Clinical trials: "Liaoning Cancer Hospital & Institute - Medical Oncology - Oncology" - 4 trials, "CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences" - 2 trials, "Affiliated Cancer Center of Academy of Military Medical Sciences" - 2 trials